# Sutent + Taxol for Advanced Esophageal Cancer

> **NCT00730353** · PHASE2 · COMPLETED · sponsor: **Hoosier Cancer Research Network** · enrollment: 28 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Sunitinib malate
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00730353
- **Lead sponsor:** Hoosier Cancer Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730353, "Sutent + Taxol for Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00730353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*